Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,961,218
  • Shares Outstanding, K 110,268
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • 60-Month Beta 1.00
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.82
Trade VKTX with:

Options Overview Details

View History
  • Implied Volatility 80.07% ( +2.78%)
  • Historical Volatility 81.25%
  • IV Percentile 16%
  • IV Rank 34.06%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.23
  • Today's Volume 11,000
  • Volume Avg (30-Day) 21,529
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 192,061
  • Open Int (30-Day) 194,560

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.24
  • Number of Estimates 10
  • High Estimate -0.21
  • Low Estimate -0.31
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -4.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.70 +20.54%
on 09/06/24
72.36 -13.88%
on 09/20/24
-3.20 (-4.88%)
since 08/26/24
3-Month
47.31 +31.73%
on 08/05/24
72.36 -13.88%
on 09/20/24
+14.93 (+31.50%)
since 06/26/24
52-Week
8.28 +652.66%
on 10/26/23
99.41 -37.31%
on 02/28/24
+50.40 (+422.60%)
since 09/26/23

Most Recent Stories

More News
Why Viking Therapeutics Stock Was So Healthy on Wednesday

Hardly for the first time, a pundit following the company waxed bullish on its future.

VKTX : 62.32 (-1.28%)
Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy?

These two stocks could be rivals in the intense GLP-1 space in the future.

VKTX : 62.32 (-1.28%)
GS : 496.92 (+1.18%)
AMGN : 319.10 (+1.99%)
Snag This Biotech Stock Before November, Here's Why

With Viking Therapeutics making a splash in the weight-loss drug arena, one analyst is encouraging investors to snap up the stock before a November catalyst.

VKTX : 62.32 (-1.28%)
NVO : 124.30 (-2.09%)
LLY : 909.32 (-1.65%)
Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

VKTX : 62.32 (-1.28%)
NVO : 124.30 (-2.09%)
LLY : 909.32 (-1.65%)
Viking Therapeutics Is Having a Year to Remember: Time to Buy?

Viking Therapeutics Inc. (NASDAQ: VKTX) has surged 238% year-to-date and 326% over the past year, far outpacing its sector and market.

VKTX : 62.32 (-1.28%)
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments

Terns has a modest market cap of less than $800 million, and its possible upside could be massive.

LLY : 909.32 (-1.65%)
GS : 496.92 (+1.18%)
TERN : 8.85 (-4.32%)
VKTX : 62.32 (-1.28%)
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030

These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.

MRK : 113.09 (-1.43%)
PFE : 28.97 (+0.14%)
MRNA : 63.93 (+0.46%)
VRTX : 463.15 (+0.30%)
VKTX : 62.32 (-1.28%)
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)

Telemedicine once seemed like it was going to revolutionize healthcare.

LLY : 909.32 (-1.65%)
PFE : 28.97 (+0.14%)
NVO : 124.30 (-2.09%)
TDOC : 8.41 (-0.71%)
AMZN : 191.16 (-0.71%)
NVDA : 124.04 (+0.43%)
SFIX : 2.53 (+11.45%)
VKTX : 62.32 (-1.28%)
ALT : 6.81 (-2.71%)
RHHBY : 40.1600 (+0.78%)
HIMS : 17.71 (+2.61%)
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.

Terns Pharmaceuticals just proved that it's competitive in the weight loss field.

VKTX : 62.32 (-1.28%)
TERN : 8.85 (-4.32%)
These 2 Biotech Stocks Are Set to Soar

Innovative drugmakers developing treatments for conditions with high unmet needs can produce lucrative wins.

VKTX : 62.32 (-1.28%)
SRPT : 124.84 (+0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 66.34
2nd Resistance Point 65.17
1st Resistance Point 63.74
Last Price 62.32
1st Support Level 61.14
2nd Support Level 59.97
3rd Support Level 58.54

See More

52-Week High 99.41
Fibonacci 61.8% 64.60
Last Price 62.32
Fibonacci 50% 53.85
Fibonacci 38.2% 43.09
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar